Crohn's Disease Clinical Trials in Philadelphia

Showing 21-40 of 52 trials

Fecal Microbiome Transplant

NCT02636517

Fecal Microbiota Transplant (FMT) in pediatric patients with recurrent C. Difficile with or without Inflammatory Bowel Disease (IBD) The aims of this study are to determine the safety and efficacy of FMT treatment in pediatric patients with recurrent or moderate to severe C. Difficile without (through an observational study) and with (through a clinical trial) Inflammatory Bowel Disease and to determine the effect of FMT on the gut microbiota through the use of 454 pyrosequencing before and after transplantation in these patients.

Clostridium DifficileInflammatory Bowel DiseaseCrohn's Disease+1 more

Judith Kelsen250 participantsStarted Dec 2015

Philadelphia, Pennsylvania, United States

COMPLETEDPHASE3< 1 mile

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385

This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.

Crohn Disease

Celgene606 participantsStarted Mar 2018

Scottsdale, Arizona, United States • La Jolla, California, United States • Lancaster, California, United States +365 more locations

Fecal Microbiome Transplant

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Crohn's Disease Trials in Other Cities

Entyvio (Vedolizumab) Long Term Safety Study

Treating IBD With Inulin

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Induction Optimization With Stelara for Crohn's Disease

Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)

B0151005 Open-Label Extension Study

A Study To Monitor Long-Term Treatment With PF-00547659

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

Other Conditions in Philadelphia